Should we screen for atrial fibrillation?

Current evidence is sufficient to justify a national screening programme, argues Mark Lown, but Patrick Moran thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ (Online) 2019-02, Vol.364, p.l43-l43
Hauptverfasser:	Lown, Mark, Moran, Patrick
Format:	Artikel
Sprache:	eng
Schlagworte:	Algorithms Anticoagulants Anticoagulants - therapeutic use Atrial Fibrillation - diagnosis Atrial Fibrillation - drug therapy Cardiac arrhythmia Cost analysis Electrocardiography Evidence-Based Medicine Fibrillation Heart Humans Mass Screening - methods Medical screening Patient Acceptance of Health Care - statistics & numerical data Risk Assessment Stroke Stroke - prevention & control Systematic review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Current evidence is sufficient to justify a national screening programme, argues Mark Lown, but Patrick Moran thinks there are too many unanswered questions and evidence from randomised trials is needed to avoid overdiagnosis
ISSN:	0959-8138 1756-1833
DOI:	10.1136/bmj.l43